BioMed Research International

Volume 2014 (2014), Article ID 236702, 6 pages

http://dx.doi.org/10.1155/2014/236702

Research Article

Association between 2/3/4, Promoter Polymorphism (−491A/T, −427T/C, and −219T/G) at the Apolipoprotein E Gene, and Mental Retardation in Children from an Iodine Deficiency Area, China

Jun Li,1,2 Fuchang Zhang,³ Yunliang Wang,⁴ Yan Wang,⁵ Wei Qin,¹ Qinghe Xing,¹ Xueqing Qian,¹ Tingwei Guo,⁶ Xiaocai Gao,³ Lin He,1,2,6 and Jianjun Gao1,2,6

¹Bio-X Institute, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai 200030, China

²Institute for Neuropsychiatric Science and Metabonomics, Changning Mental Health Center, Shanghai 200335, China

³Key Laboratory of Resource Biology and Biotechnology in Western China (Ministry of Education), College of Life Science, Institute of Population and Health, Northwest University, Xi’an 710069, China

⁴Department of Neurology, the 148th Hospital, Zibo, Shandong 255300, China

⁵Shanghai Institute of Planned Parenthood Research, 200013, Shanghai, China

⁶Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of Chinese Academy Sciences, Shanghai 200031, China

Received 16 January 2014; Accepted 18 February 2014; Published 25 March 2014

Academic Editor: Shiwei Duan

Copyright © 2014 Jun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Several common single-nucleotide polymorphisms (SNPs) at apolipoprotein E (ApoE) have been linked with late onset sporadic Alzheimer’s disease and declining normative cognitive ability in elder people, but we are unclear about their relationship with cognition in children. Results. We studied , , and promoter polymorphisms and at ApoE among children with mental retardation (MR, ), borderline MR (), and controls () from an iodine deficiency area in China. The allelic and genotypic distribution of individual locus did not significantly differ among three groups with Mantel-Haenszel test (). However, frequencies of haplotype of /// were distributed as MR > borderline MR > controls ( uncorrected = 0.004), indicating that the presence of this haplotype may increase the risk of disease. Conclusions. In this large population-based study in children, we did not find any significant association between single locus of the four common ApoE polymorphisms (, , , and ) and MR or borderline MR. However, we found that the presence of ATT haplotype was associated with an increased risk of MR and borderline MR. Our present work may help enlarge our knowledge of the cognitive role of ApoE across the lifespan and the mechanisms of human cognition.

1. Introduction

Mental retardation (MR) is a condition of neuropsychiatric dysfunction featured by an impairment of intellectual abilities and a deficit of adaption to the environment and the social milieu [1]. Among the complex potential causes of MR, iodine deficiency constitutes the world’s greatest single cause of preventable MR [2]. Children born in iodine deficient areas are at great risk for loss of intelligence quotient (IQ) caused by the combined effects of maternal, fetal, and neonatal hypothyroxinemia [3].

Familial aggregation of MR is common in the Qin-Ba Mountain region (Qinba) in midwestern China. Our previous investigation demonstrated that nonspecific mental retardation (NSMR) in Qinba has a heritability with 58.2% (%) and may be determined by a lot of minor effective genes [4]. Numeric associations between general intelligence and specific single-nucleotide polymorphisms (SNPs) in several candidate genes involved in brain function have been reported [5, 6]. Apolipoprotein E (ApoE) plays an important role in cholesterol transport and plasma lipoprotein metabolism [7]. Several overlapping functions have been attributed to ApoE potentially, such as lipid transport, neuronal repair, dendritic growth, maintenance of synaptic plasticity, and anti-inflammatory activities [8]. Its potential role in brain functioning is wide ranging. The common variations of ApoE-2/3/4, defined by two common SNPs (rs7412 for ApoE 2 and rs429358 for ApoE 4) [9], are the best established susceptibility gene for late-onset Alzheimer’s disease (AD) [10, 11]. They were also linked with declining cognitive ability in older people without Alzheimer’s disease [12]. The hypothesis that ApoE 4 is also associated with cognitive decline in old age has been investigated in a few studies with inconsistent results. Despite the existing inconsistency, accumulating evidence or stronger effect on intelligence was found in the older people; by contrast, fewer pieces of evidence were found in younger people. Recently, a few studies have examined the association between cognition and the common ApoE polymorphisms in children or younger adults, but the results were inconsistent [13, 14].

In addition to the ApoE-2/3/4 polymorphisms in coding sequence, other common polymorphisms in promoter including −491A/T (numbered relatively to the transcription start site, rs449647), −427T/C (rs769446), and −219G/T (rs405509) were linked with the quantitative expression of ApoE [15, 16] and associated with AD [17–22]. However, to the best of our knowledge, only one study has looked into whether these polymorphisms are related to intelligence in children individually [13]. No study has investigated the haplotype constituting the polymorphisms in promoter and ApoE-2/3/4. Their relationship to intelligence at an early age is a thought of particular interest, because it would potentially aid in understanding the role of ApoE for cognitive functioning across the lifespan [14, 23] and the nature of human cognitive mechanisms.

2. Materials and Methods

2.1. Subjects

Between 1995 and 1998, we carried out an investigation on MR in two areas with high risk in Qinba Mountains, Zhashui county and Ankang county. Among the two counties, some typical villages with high risk of MR were selected as the target areas in our investigation. All children aged 0–14 years from these areas ( in Zhashui and in Ankang) were recruited and then screened by different instruments/scales. Details about the study design can be found elsewhere [24]. Briefly, based on the Chinese Classification of Mental Disorders 2nd Revision and the classification of mental and behavioral disorders from the World Health Organization (WHO), the clinical psychiatric pediatricians diagnosed, identified, and classified the MR or borderline MR in the Qinba region of China. We also drew family pedigrees to investigate if there existed possible familial mental retardation. All subjects were Han Chinese in origin. We also collected peripheral blood samples from children aged 6–14 years because they were more collaborated. Blood specimens were saved under −70°C until the analysis. The protocol was reviewed and approved by the Ethical Committee of the National Human Genome Center. The guardians of all participated children provided written informed consent.

2.2. Assessment of Mental Retardation

For children aged 6–14 years, we first screened their intelligence using Chinese Standardization of Raven’s Standard Progressive Matrices [25]. If children’s IQ <85, we assessed their adaptive behavior using Chinese Revised Scale of Social Adaption Ability of Infant-Junior Middle School Student [26]. For children with scores of adaption ability ≤9, we reassessed their intelligence with Chinese-Wechsler Intelligence Scale for Children [27]. MR or borderline MR was finally diagnosed by professional assessment of intelligence and adaptive behavior according to the International Classification of Diseases-10 (1990, WHO).

2.3. Genotyping

A total of 588 blood samples were drawn from children aged 6–14 years with MR (), borderline MR (), and non-MR (controls, ).

Leukocyte DNA was extracted using a standard phenol/chloroform method. ApoE promoter polymorphisms −491A/T, −427T/C, and −219G/T were genotyped via a nested PCR amplification. Firstly, the parent 1426 bp fragment was amplified using the primers 5′-CAAGGTCACACAGCTGGCAAC-3′ (forward) and 5′-TCCAATCGACGGCTAGCTACC-3′ (reverse) [17] under the following conditions: (1) 94°C for 5 min, 1 cycle, (2) 94°C for 50 s, 65°C for 50 s, and 72°C for 1 min, 35 cycles, and (3) 72°C for 10 min, 1 cycle and stored at 4°C. The PCR product above was then diluted and used as the templates for the 471 bp fragment amplification with the primers 5′-CACCACGCCTGGCTAACTT-3′ (forward) and 5′-TCACGAGGTGGGCTGTTCT-3′ (reverse) under the following conditions: (1) 95°C for 3 min, 1 cycle, (2) 95°C for 30 s and 68°C for 1 min, 37 cycles, and (3) 72°C for 10 min, 1 cycle and stored at 4°C. The PCR products were subsequently treated according to the standard sequencing procedure of BigDye Terminator v3.1 Cycle Sequencing Kit in the PE Applied Biosystem (PE Applied Biosystem) using either the forward primer or the reverse primer. Electrophoresis was conducted on the ABI PRISM 3100 Genetic Analyzer (PE Applied Biosystem). ApoE-2/3/4 genotypes were determined by sequencing and restriction fragment length polymorphism (RFLP) as described in our earlier work [28].

2.4. Statistical Analysis

Genotype and allele frequencies of ApoE and promoter polymorphisms were determined in study groups. Hardy-Weinberg equilibrium and putative haplotypes estimation analysis for −491A/T, −427T/C, −219G/T, and ApoE-2/3/4 were calculated using the software program ARLEQUIN (version 2.0; Genetics and Biometry Laboratory, University of Geneva, Switzerland) [29]. All comparisons for differences of allele, genotype, and haplotype distributions among groups of MR, borderline MR, and controls were tested with Mantel-Haenszel test using SAS 9.2 (SAS, Cary, NC). Finally, pairwise linkage disequilibrium coefficients ( and ) were calculated using the EMLD program developed by Qiqing Huang (http://www.mybiosoftware.com/population-genetics/4717).

3. Results

The distributions of gender, age, and counties did not differ significantly among MR, borderline MR, and controls (, Table 1). The individual allelic and genotypic frequencies of −491A/T, −427T/C, −219G/T, and ApoE-2/3/4 by study groups were shown in Table 2. The distributions of genotypes of all the selected loci were in Hardy-Weinberg equilibrium (). Comparisons among MR, borderline MR, and control groups with Mantel-Haenszel test did not find any significant difference in allele or genotype distributions (). However, the comparison of the haplotype frequencies among three study groups revealed that (Table 3) haplotype between the promoter polymorphisms −491A, −427T, −219T, and 4 was significantly associated with the phenotypes showing the high frequency in MR, lower frequency in borderline MR, and the lowest frequency in controls (Mantel-Haenszel , uncorrected ). LD between all possible pairs of the four polymorphisms was calculated and the pairwise and were shown in Table 4.

Table 1: Population characteristics according to case and control.

County

Sex ratio (F : M)
Mean age SD

Control
Zhashui
250
117/133

Ankang
84
37/47

Bordera
Zhashui
80
42/38

Ankang
44
22/22

MRb
Zhashui
73
38/35

Ankang
57
27/30

Sum
588
283/305

Borderline mental retardation (border) group.

bMental retardation (MR) group.

Table 2: Distribution of allele and genotype across ApoE 2/3/4,  −491A/T, −427T/C, and −219G/T polymorphisms in MR, borderline MR, and control.

Loci

Allele

Genotype

3
4

2+c
4+c
3/3

2/3/4

    MR
260
26 (23.4)
206 (21.4)
28 (26.9)
0.82
130
24 (23.4)
80 (20.3)
26 (28.3)
0.46

    Borderline MR
248
20 (18.0)
211 (22.0)
17 (16.4)
123a
18 (18.0)
89 (22.5)
16 (17.4)

    Control
668
65 (58.6)
544 (56.6)
59 (56.7)
329a
53 (58.6)
226 (57.2)
50 (54.3)

T
A

T/T
T/A
A/A

−491A/T

    MR
260
3 (14.3)
257 (22.2)

0.21
130
0 (0)
3 (15.8)
127 (22.4)
0.45

    Borderline MR
248
3 (14.3)
245 (21.1)

124
0 (0)
3 (15.8)
121 (21.3)

    Control
668
15 (71.4)
653 (56.7)

334
1 (100)
13 (68.4)
320 (56.3)

C
T

C/C
C/T
T/T

−427T/C

    MR
260
24 (21.8)
236 (22.1)

0.64
130
1 (14.3)
22 (22.9)
107 (22.1)
0.49

    Borderline MR
248
20 (18.2)
228 (21.4)

124
0 (0)
20 (20.8)
104 (21.4)

    Control
668
66 (60.0)
602 (56.5)

334
6 (85.7)
54 (56.3)
274 (56.5)

G
T

G/G
G/T
T/T

−219G/T

    MR
260
81 (22.2)
179 (22.0)

0.77
130
16 (26.2)
49 (20.2)
65 (23.6)
0.78

    Borderline MR
248
72 (19.8)
176 (21.7)

124
10 (16.4)
52 (21.5)
62 (18.9)

    Control
668
211 (58.0)
457 (56.3)

334
35 (57.4)
141 (58.3)
158 (57.4)

Counts of alleles or genotypes may not add up to total due to excluding the individuals genotyped as 2/4.

b values are from Mantel-Haenszel test in which MR, borderline MR, and control are ordinal variables.

c2+: 2/2 + 2/3; ε4+: 3/4 + 4/4.

Table 3: Estimated haplotype frequencies for linkage disequilibrium among ApoE −491,  −427, −219, and 2/3/4.

Haplotypea
Frequency
MR

()
Borderline MR

()
Control

()
Mantel-Haenszel
valueb

Uncorrected
Corrected

ATTε2
0.06
0.07
0.02
0.06
0.0005
0.98
1.00

ATGε3
0.19
0.19
0.22
0.18
0.37
0.54
1.00

ATTε3
0.55
0.51
0.60
0.55
0.40
0.53
1.00

ATTε4
0.07
0.10
0.07
0.05
8.09
0.004
0.02

ACGε2
0.02
0.01
0.06
0.02
0.03
0.87
1.00

ACGε3
0.06
0.08
0.01
0.07
0.07
0.80
1.00

Haplotypes are from alleles of 4 polymorphisms: ApoE −491, −427, −219, and 2/3/4. Only the haplotypes with frequency 0.01 and higher are shown.

bCorrected value according to Bonferroni correction (6 tests).

Table 4: Pairwise linkage disequilibrium (/) of −491A/T, −427T/C, −219T/G, and 2/3/4 polymorphisms.

SNPs
LD estimate ( or ) for marker pair

−491A/T
−427T/C
−219T/G
ε2/ε3/ε4

−491A/T
—
0.921
0.241
0.216

−427T/C
0.002
—
0.895
0.589

−219T/G
0.001
0.171
—
0.286

ε2/ε3/ε4
0.001
0.075
0.049
—

The standardized values are shown above the diagonal, and the values are shown below the diagonal.

4. Discussion

In this study, we investigated if ApoE-2/3/4 and promoter polymorphisms of −491A/T, −427T/C, and −219G/T are associated with the risk of MR in children from the iodine deficiency area with high prevalence of MR. We did not find any significant association between individual variation at four common polymorphisms (−491A/T, −427T/C, −219T/G, and 2/3/4) and MR or borderline MR. Interestingly, haplotype analysis showed that ATT4 is associated with increased risk of MR and borderline MR.

The physiological and pathological roles of ApoE in the central nervous systems are not entirely clear, but ApoE protein is produced in abundance in the brain by glia, macrophages, and neurons [30, 31]. It is well known that ApoE 4 is a major genetic risk factor for late onset sporadic AD [10, 22] and has also been investigated for its association not only with dementia but also with normative cognitive development. Most studies have been conducted on adults, especially on older people, but much fewer studies have explored the relationship of ApoE and cognition in children. Several studies on ApoE genotype in relation to cognition in children showed inconsistent results. Most prior studies in school-aged children did not find any significant association with cognitive performance or school assessments, measured in different ways [5, 13, 14, 32], although one study detected a significant association with general cognitive factor [33] and ApoE 4 predicted higher education in another study [34]. Cavani et al. investigated the association between ApoE genotype and MR in Down syndrome patients in 2000 and found no statistical differences between ApoE allele frequencies of Down syndrome, normal controls, and MR cases [35]. Our analyses based on individual locus found null associations with mental retardation, which is consistent with the prior studies with null associations. Interestingly, haplotype analysis suggested that ApoE may have relationship with intelligence in children. It may be very well helpful for future studies to include haplotype analysis.

To the best of our knowledge, our study is the first attempt to examine haplotype association of ApoE promoter and 2/3/4 with intelligence in children. Therefore, our analyses should be considered as exploratory and hypothesis generating. The association should be interpreted with cautions although the significance can pass the Bonferroni correction (threshold tests). Due to moderate sample size, we could not exclude the possibility of chance finding. An alternative explanation for the positive association is that our subjects had some specialties compared to other studies. The samples in the study were recruited from the relatively isolated iodine deficiency area. The iodine deficient exposure may bring some new features to increase the feasibility of detection. The exon 3 of the ApoE gene possesses sequence homology with coding of the three major thyroid hormone plasma transport proteins (thyroid-binding globulin (TBG), transthyretin (TTR), and albumin) [36, 37]. If the ApoE genotypic variation affects the efficiency of transportation and metabolism of thyroid hormone and therefore influences neuronal cell growth during the first and second trimesters of fetal development [38, 39], the effect size of association between ApoE and intelligence can be modified by the exposure of iodine deficiency. This hypothesis needs confirmation from other studies. On the other hand, MR and borderline MR can be regarded as extreme outcomes of intelligence. Using the extreme phenotypes can increase the power to detect association.

The samples in the study were recruited from the relatively isolated Qinba mountainous area and we did not find a significant difference in allele frequencies among the two counties, which indicated lower risk of stratification bias. Due to the fact of poor education, less developed economy, and transportation, the area is almost isolated from other areas and has much less gene flow [28], so the subjects are helpful in controlling population stratification and have the advantage from the view of a genetic investigation [40, 41].

5. Conclusions

In summary, in this large population-based study, we did not find any significant association between single locus of the four common ApoE polymorphisms (−491A/T, −427T/C, −219T/G, and 2/3/4) and MR or borderline MR in children. However, we found that the presence of ATT4 haplotype was associated with an increased risk of MR and borderline MR. Our present work may help enlarge our knowledge of the role of ApoE in cognitive functioning across the lifespan and the mechanisms of human cognition.

Abbreviations

ApoE: | Apolipoprotein E
MR: | Mental retardation
IQ: | Intelligence quotient
NSMR: | Nonspecific mental retardation
SNP: | Single-nucleotide polymorphism
AD: | Alzheimer’s disease
RFLP: | Restriction fragment length polymorphism.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Jianjun Gao, Fuchang Zhang, and Lin He planned and supervised the study. Fuchang Zhang and Lin He gained funding for this study. Jianjun Gao, Tingwei Guo, and Fuchang Zhang collected the blood samples. Jianjun Gao and Jun Li conducted the experiments. Jianjun Gao, Jun Li, and Yan Wang analyzed data and wrote the final version. Yunliang Wang, Wei Qin, Qinghe Xing and Xueqing Qian provided intellectual inputs and revised the paper. All the authors read and approved the final paper and submission. Jun Li, Fuchang Zhang, and Yunliang Wang contributed equally to this work.

Acknowledgments

The authors sincerely thank all participants in this study, particularly Drs. Ruilin Li, Zhenlin Wang, and Hongxing Dai. This work was supported by Grants from the Ministry of Education, China, the National Natural Science Foundation of China, the Shanghai Municipal Commission for Science and Technology, the national 863 Project and 973 Project (no. 2002BA711A07-01), and “the Tenth Five-Year Plan” National Tackle Problem Item (no. 2001BA901A49).

References

A. P. Association, Diagnostic and Statistical Manual of Mental Disorders, The American Psychiatric Association, Washington, DC, USA, 4th edition, 1994.

F. Delange, “The role of iodine in brain development,” Proceedings of the Nutrition Society, vol. 59, no. 1, pp. 75–79, 2000.

D. Glinoer and F. Delange, “The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny,” Thyroid, vol. 10, no. 10, pp. 871–887, 2000.

K. J. Zhang, K. J. Z. F, Z. J. Zheng et al., “An analysis of inheriting type of non-causing mental retarded children in Zhashui experimental station,” Joumal of Northwest University, vol. 35, pp. 597–600, 2005.

C. F. Chabris, B. M. Hebert, D. J. Benjamin, et al., “Most reported genetic associations with general intelligence are probably false positives,” Psychological Science, vol. 23, no. 11, pp. 1314–1323, 2012.

L. M. Houlihan, S. E. Harris, M. Luciano et al., “Replication study of candidate genes for cognitive abilities: The Lothian Birth Cohort 1936,” Genes, Brain and Behavior, vol. 8, no. 2, pp. 238–247, 2009.

K. H. Weisgraber and R. W. Mahley, “Human apolipoprotein E: the Alzheimer's disease connection,” The FASEB Journal, vol. 10, no. 13, pp. 1485–1494, 1996.

D. K. Lahiri, K. Sambamurti, and D. A. Bennett, “Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 5, pp. 651–660, 2004.

J. Gao, X. Huang, Y. Park et al., “Apolipoprotein E genotypes and the risk of Parkinson disease,” Neurobiology of Aging, vol. 32, no. 11, pp. 2106.e1–2106.e6, 2011.

L. A. Farrer, L. A. Cupples, J. L. Haines et al., “Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis,” The Journal of the American Medical Association, vol. 278, no. 16, pp. 1349–1356, 1997.

K. I. Morley and G. W. Montgomery, “The genetics of cognitive processes: candidate genes in humans and animals,” Behavior Genetics, vol. 31, no. 6, pp. 511–531, 2001.

O. J. G. Schiepers, S. E. Harris, A. J. Gow et al., “APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921,” Molecular Psychiatry, vol. 17, no. 3, pp. 315–324, 2012.

D. Turic, P. J. Fisher, R. Plomin, and M. J. Owen, “No association between apolipoprotein E polymorphisms and general cognitive ability in children,” Neuroscience Letters, vol. 299, no. 1-2, pp. 97–100, 2001.

A. E. Taylor, P. A. I. Guthrie, G. D. Smith et al., “IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein e genotype in 5995 children,” Biological Psychiatry, vol. 70, no. 2, pp. 152–158, 2011.

J.-C. Lambert, C. Berr, F. Pasquier et al., “Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease,” Human Molecular Genetics, vol. 7, no. 9, pp. 1511–1516, 1998.

J. D. Smith, A. Melian, T. Leff, and J. L. Breslow, “Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements,” The Journal of Biological Chemistry, vol. 263, no. 17, pp. 8300–8308, 1988.

T. Town, D. Paris, D. Fallin et al., “The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism,” Neuroscience Letters, vol. 252, no. 2, pp. 95–98, 1998.

S. Helisalmi, M. Hiltunen, P. Valonen et al., “Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals,” Journal of Neurology, vol. 246, no. 9, pp. 821–824, 1999.

A. Juhász, A. Palotás, Z. Janka et al., “ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the ε4 allele in Hungarian Alzheimer's dementia population,” Neurochemical Research, vol. 30, no. 5, pp. 591–596, 2005.

G. Parra-Bonilla, G. Arboleda, J. Yunis et al., “Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients,” Neuroscience Letters, vol. 349, no. 3, pp. 159–162, 2003.

B. T. Heijmans, P. E. Slagboom, J. Gussekloo, et al., “Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age,” American Journal of Medical Genetics, vol. 107, no. 3, pp. 201–208, 2002.

X.-Y. Xin, J.-Q. Ding, and S.-D. Chen, “Apolipoprotein e promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis,” Journal of Alzheimer's Disease, vol. 19, no. 4, pp. 1283–1294, 2010.

O. Sternång and Å. Wahlin, “What is the role of apolipoprotein e for cognitive functioning across the lifespan?” Biological Psychiatry, vol. 70, no. 2, pp. 109–110, 2011.

J. Gao, X. Gao, W. Qin et al., “No observable relationship between the ACE gene insertion/deletion polymorphism and psychometric IQ and psychomotor ability in Chinese children,” Neuropsychobiology, vol. 53, no. 4, pp. 196–202, 2006.

H. Zhang and X. P. Wang, “Chinese standardisation of Raven's Standard Progressive Matrices,” Psychological Test Bulletin, vol. 2, no. 11, pp. 36–39, 1989.

Q. Zuo, Z. Zhang, and W. Liang, Social Adaption Ability of Infant-Junior Middle School Student, Beijing Medical University, Beijing, China, 1988.

Y. Gong and X. Y. Dai, “China-Wechsler younger children scale of intelligence (CWYCSI),” Acta Psychologica Sinica, vol. 20, pp. 364–375, 1988.

J. Gao, F. Zhang, T. Guo et al., “Distribution of apolipoprotein E allele frequencies of the Han Chinese in an iodine-deficient mountainous area,” Annals of Human Biology, vol. 31, no. 5, pp. 578–585, 2004.

L. Excoffier, G. Laval, and S. Schneider, “Arlequin (version 3. 0): an integrated software package for population genetics data analysis,” Evolutionary Bioinformatics Online, vol. 1, pp. 47–50, 2005.

R. E. Pitas, J. K. Boyles, and S. H. Lee, “Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins,” Biochimica et Biophysica Acta, vol. 917, no. 1, pp. 148–161, 1987.

D. A. Elliott, W. S. Kim, D. A. Jans, and B. Garner, “Apoptosis induces neuronal apolipoprotein-E synthesis and localization in apoptotic bodies,” Neuroscience Letters, vol. 416, no. 2, pp. 206–210, 2007.

I. J. Deary, M. C. Whiteman, A. Pattie et al., “Ageing: cognitive change and the APOE ε4 allele,” Nature, vol. 418, no. 6901, p. 932, 2002.

M. Luciano, A. J. Gow, S. E. Harris et al., “Cognitive ability at age 11 and 70 years, information processing speed, and APOE variation: the Lothian Birth Cohort 1936 Study,” Psychology and Aging, vol. 24, no. 1, pp. 129–138, 2009.

J. A. Hubacek, J. Pitha, Z. Škodová, V. Adámková, V. Lánská, and R. Poledne, “A possible role of apolipoprotein E polymorphism in predisposition to higher education,” Neuropsychobiology, vol. 43, no. 3, pp. 200–203, 2001.

S. Cavani, A. Tamaoka, A. Moretti, et al., “Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome,” American Journal of Medical Genetics, vol. 95, no. 3, pp. 224–228, 2000.

S. Benvenga, “A thyroid hormone binding motif is evolutionarily conserved in apolipoproteins,” Thyroid, vol. 7, no. 4, pp. 605–611, 1997.

S. Benvenga, H. J. Cahnmann, D. Rader, M. Kindt, and J. Robbins, “Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3,” Endocrinology, vol. 131, no. 6, pp. 2805–2811, 1992.

S. Benvenga, H. J. Cahnmann, and J. Robbins, “Characterization of thyroid hormone binding to apolipoprotein-E: localization of the binding site in the exon 3-coded domain,” Endocrinology, vol. 133, no. 3, pp. 1300–1305, 1993.

C. Xue-Yi, J. Xin-Min, D. Zhi-Hong et al., “Timing of vulnerability of the brain to iodine deficiency in endemic cretinism,” The New England Journal of Medicine, vol. 331, no. 26, pp. 1739–1744, 1994.

S. Shifman and A. Darvasi, “The value of isolated populations,” Nature Genetics, vol. 28, no. 4, pp. 309–310, 2001.

T. Laitinen, “The value of isolated populations in genetic studies of allergic diseases,” Current Opinion in Allergy and Clinical Immunology, vol. 2, no. 5, pp. 379–382, 2002.